November 4
Britain’s medicines regulator said on Thursday it had approved a COVID-19 antiviral oral pill jointly developed by Merck and Ridgeback Biotherapeutics, the first country to clear a potentially game-changing therapy for the illness.- Reuters
(The article is generated from The Tribune via feeds, The Chenab Times staff didn’t wrote this news.)
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk